Immunic Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Feb 24 | BuyUS$18,333 | Daniel Vitt | Individual | 14,000 | US$1.31 | |
15 May 23 | BuyUS$8,750 | Glenn Whaley | Individual | 5,000 | US$1.75 |
Insider Trading Volume
Insider Buying: IMUX insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,711 | 0.00524% |
Individual Insiders | 867,173 | 0.964% |
Institutions | 21,333,537 | 23.7% |
General Public | 28,049,884 | 31.2% |
Hedge Funds | 39,673,711 | 44.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 102.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,983,908 | US$11.4m | 107% | 0.2% | |||
8,902,972 | US$11.3m | 675% | 0.28% | |||
8,899,418 | US$11.3m | 0% | 0.44% | |||
7,293,007 | US$9.3m | 2,330% | 1.01% | |||
6,693,007 | US$8.5m | 0% | no data | |||
5,594,406 | US$7.1m | 0% | 0.01% | |||
2,162,782 | US$2.7m | 0% | 1.37% | |||
1,974,571 | US$2.5m | 0% | 100.0% | |||
1,941,454 | US$2.5m | 15.1% | 0.14% | |||
1,788,160 | US$2.3m | 0% | 1.57% | |||
1,691,000 | US$2.1m | 1.71% | no data | |||
600,234 | US$762.3k | -21.2% | 0.07% | |||
559,305 | US$710.3k | -26.1% | no data | |||
421,184 | US$534.9k | 0% | 0.06% | |||
417,613 | US$530.4k | 5.29% | no data | |||
390,877 | US$496.4k | 3.71% | no data | |||
362,126 | US$459.9k | 1.49% | no data | |||
334,953 | US$425.4k | 44% | no data | |||
324,829 | US$412.5k | 0% | 0.12% | |||
317,059 | US$402.7k | 0% | 0.02% | |||
305,311 | US$387.7k | 0% | no data | |||
272,457 | US$346.0k | 0% | 0.12% | |||
164,439 | US$208.8k | 49.2% | no data | |||
147,418 | US$187.2k | -53.6% | no data | |||
129,700 | US$164.7k | -45.7% | no data |